Titan Medical Inc.

    Titan Medical Inc.

    TTSX:TMD
    - -
    CAD
    - -
    - -
    29.73P/E
    Titan Medical Inc.
    TSX:TMD
    (Toronto Stock Exchange)

    Recent

    price

    - -

    P/E

    ratio

    29.73

    div

    yld

    - -

    ROIC.AI

    2008
    2009
    2010
    2011
    2012
    2013
    2014
    2015
    2016
    2017
    2018
    2019
    2020
    2021
    2022
    2023
    TTM
    USD
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    0.3
    0.19
    - -
    0.16
    0.01
    Revenue per Share
    -2.94
    -0.64
    -2.62
    -8.73
    -3.65
    -3.75
    -4.29
    -11.92
    -4.77
    -4.25
    -1.36
    -1.37
    -0.36
    -0.14
    -0.38
    0.06
    -0.04
    Basic EPS, GAAP
    -2.55
    -0.37
    -2.23
    -8.45
    -3.68
    -3.31
    -4.33
    -9.91
    -7.24
    -2.44
    -2.51
    -1.51
    -0.02
    -0.34
    -0.26
    0.04
    -0.06
    Free Cash Flow per Basic Share
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Dividend per Share
    -3.37
    -3.39
    -5.4
    0.33
    -2.18
    -3.52
    6.74
    -2.1
    -0.81
    0.47
    -0.15
    -0.65
    -0.36
    0.09
    -0.29
    -0.21
    -0.22
    Book Value per Share
    1.63
    2.55
    6.35
    4.95
    1.95
    0.76
    9.34
    -0.25
    - -
    1.12
    0.18
    -0.43
    -0.23
    0.31
    -0.05
    0.04
    0.02
    Tangible Book Value per Share
    1
    1
    1
    2
    2
    2
    3
    3
    5
    8
    17
    31
    67
    108
    112
    113
    114
    Basic Weighted Avg Shares
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    20
    20
    - -
    18
    1
    Sales/Revenue/Turnover
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    20.76
    -153.86
    - -
    50.75
    -240.53
    Operating Margin (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    1
    1
    - -
    - -
    Depreciation Expense
    -2
    -1
    -4
    -16
    -8
    -9
    -13
    -41
    -23
    -34
    -23
    -42
    -24
    -15
    -43
    7
    -5
    Net Income, GAAP
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    0.34
    - -
    Effective Tax Rate (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    -120.92
    -73.95
    - -
    39.43
    -531.26
    Profit Margin (%)
    1
    3
    9
    9
    4
    2
    29
    -1
    - -
    9
    3
    -13
    -16
    33
    -4
    6
    3
    Working Capital
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    1
    1
    1
    1
    1
    LT Debt
    1
    3
    9
    9
    4
    2
    30
    - -
    1
    10
    4
    -12
    -14
    35
    -3
    5
    3
    Total Equity
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    381.36
    - -
    Return on Invested Capital (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    -27.44
    -1.52
    Return on Capital (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Common Equity (%)

    Capital Structure

    USD

    •

    in mil. unless spec.
    Dec'23
    Mar'24
    Jun'24
    ST Debt
    - -
    - -
    1
    LT Borrowings
    - -
    - -
    - -
    LT Finance Leases
    1
    1
    1
    Preferred Equity and Hybrid Capital
    - -
    - -
    - -
    Shares Outstanding
    114
    114
    114
    Market Capitalization
    170
    157
    104

    Working Capital

    USD

    •

    in mil. unless spec.
    Dec'23
    Mar'24
    Jun'24
    Total Current Assets
    9
    7
    4
    Cash, Cash Equivalents & STI
    8
    6
    4
    Accounts Receivable, Net
    - -
    - -
    - -
    Inventories
    - -
    - -
    - -
    Total Current Liabilities
    3
    2
    1
    Payables & Accruals
    3
    2
    1
    ST Debt
    - -
    - -
    1
    Deferred Revenue
    - -
    - -
    - -

    Growth Rates

    USD

    •

    in mil. unless spec.

    (avg. rate of change)

    10 years
    5 years
    1 year
    Total Equity
    140.52%
    -214.91%
    -251.23%
    Free Cash Flow
    256.56%
    452.62%
    -115.62%
    Net Income, GAAP
    30.3%
    14.85%
    -116.34%
    Sales/Revenue/Turnover
    - -
    - -
    - -
    Total Cash Common Dividend
    - -
    - -
    - -

    Quarterly Revenue

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2022
    - -
    - -
    - -
    - -
    - -
    2023
    - -
    17
    - -
    1
    18
    2024
    - -
    - -
    - -
    - -
    - -

    Quarterly Earnings Per Share

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2022
    -0.08
    -0.1
    -0.09
    - -
    -0.38
    2023
    -0.02
    0.12
    - -
    - -
    0.06
    2024
    -0.01
    -0.01
    - -
    - -
    - -

    Quarterly Dividends Per Share

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2022
    - -
    - -
    - -
    - -
    - -
    2023
    - -
    - -
    - -
    - -
    - -
    2024
    - -
    - -
    - -
    - -
    - -
    Similar Companies
    Business